Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2years

Author:

Gallwitz, B.; Rosenstock, J.; Emser, A.; von Eynatten, M.; Woerle, H-J.

Tübinger Autor(en):

Published in:

International Journal of Clinical Practice (2013), Bd. 67, H. 4, S. 317-321

Verlagsangabe:

Wiley - Blackwell

Language:

English

Full text:

ISSN:

1368-5031

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)